Dr. Collins brings multi-disciplinary expertise in the design and construction of synthetic gene circuits and programmable cells Cambridge, MA – January 11, 2019. Asimov, the synthetic biology company building a genetic design platform for molecular manufacturing and therapeutic applications, announced today it has appointed Dr. James J. Collins as its inaugural Scientific Advisory Board member. […]